Cargando…
Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors
Oncolytic viruses (OVs) have emerged as a very promising anti-cancer therapeutic strategy in the past decades. However, despite their pre-clinical promise, many OV clinical evaluations for cancer therapy have highlighted the continued need for their improved delivery and targeting. Mesenchymal strom...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989711/ https://www.ncbi.nlm.nih.gov/pubmed/35434272 http://dx.doi.org/10.1016/j.omto.2022.03.008 |